Please login to the form below

Not currently logged in
Email:
Password:

NCI

This page shows the latest NCI news and features for those working in and with pharma, biotech and healthcare.

AZ’s comeback drug cediranib stumbles in phase 3 trial

AZ’s comeback drug cediranib stumbles in phase 3 trial

A phase 2 NCI trial reported in 2014 showed that cediranib plus Lynparza was able to nearly double progression-free survival (PFS) compared to Lynparza alone in patients who had either ... The NCI is carrying out the phase 2/3 GY005 trial of Lynparza

Latest news

More from news
Approximately 1 fully matching, plus 31 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • ASCO 2015: What you missed in Chicago

    The second area that really impressed me was the large National Cancer Institute (NCI) trial[3] that will look to treat patients with solid tumours based on their genetic mutations and ... Larkin et al 2015 NEJM[3] NCI Prepares to Launch MATCH Trial.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
HAVAS Just::

HAVAS Just:: is a different kind of healthcare communications agency. Our mission is to create campaigns that make people think....

Latest intelligence

AI and genomics: a revolution in drug discovery and development
...
Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....

Infographics